The Center for Early Detection and Interception of Solid Tumors help patients manage precursor conditions and genetic predispositions for solid tumor cancers, including gastrointestinal, gynecologic, and head and neck tumors.
Our specialized centers evaluate individuals at high risk for developing these conditions and work with patients to manage their risk of disease progression.
Our Specialty Centers and Programs
Gastrointestinal Tumors
Center for Early Detection and Interception of Gastrointestinal Tumors specializes in precursor conditions of gastrointestinal cancers — including precusor lesions of the esophagus, stomach, pancreas, and colon. We provide individualized plans to lower your chances of developing these cancers if you are at elevated risk. We offer comprehensive evaluation for individuals with Barrett’s esophagus, gastric polyps, gastric intestinal metaplasia (GIM), gastric neuroendocrine tumors (gNETs), pancreatic neuroendocrine tumors (pNETs), intraductal papillary mucinous neoplasms (IPMNs), and colorectal polyps.
Gynecologic Tumors
Center for Early Detection and Interception of Gynecologic Tumors specializes in precursor conditions of gynecologic cancers and hereditary syndromes associated with elevated risk of gynecologic tumors — including ovarian, endometrial/uterine, and fallopian tube. We provide customized plans for individuals at higher risk of developing these cancers. This includes patients with known genetic mutations such as BRCA and Lynch syndrome, as well as those with a family history of ovarian or uterine cancers without a genetic mutation.
Oral Medicine
We specialize in precursor conditions of head and neck tumors such as oral leukoplakia.
Multi-Cancer Early Detection Clinic
Multi-Cancer Early Detection Clinic provides comprehensive diagnostic evaluations for patients with a positive multi-cancer early detection (MCED) test, such as the GRAIL Galleri test. Using a single blood sample, MCED tests screen for numerous types of cancers — including breast, cervical, colorectal, and prostate cancers.
Dana-Farber patients who have had cancer previously, and are now in remission, can request an MCED test at our clinic.